The system, which will launch first in the EU and then the US and China, will be integrated into the company's existing Cobas Pro Integrated Solutions analyzer.
Launched in Europe in 2018 and the US in 2020, the fully automated mass spec-based analyzer failed to gain market traction, in large part due to a limited assay menu.
Danaher Q2 Revenues Spike 19 Percent
For the three months ended July 3, the Washington DC-based conglomerate recorded $5.30 billion in total sales compared to $4.44 billion in the year-ago period.
Clinical Mass Spec Sees Shakeup as Sciex Shuts Down Topaz, Thermo Launches Cascadion in US
Sciex has discontinued the Topaz platform three years after its launch while Thermo Fisher aims to drive adoption of its Cascadion following a recent US launch.
Danaher Q3 Revenues Up 4 Percent
The company's life sciences revenues were up 6 percent while its diagnostics business grew almost 7 percent.